PT1651774E - Utilização de polimorfismos na oatp-c humana, associados com um efeito sobre a farmacocinética da estatina, em humanos em terapia com estatina - Google Patents

Utilização de polimorfismos na oatp-c humana, associados com um efeito sobre a farmacocinética da estatina, em humanos em terapia com estatina Download PDF

Info

Publication number
PT1651774E
PT1651774E PT04743565T PT04743565T PT1651774E PT 1651774 E PT1651774 E PT 1651774E PT 04743565 T PT04743565 T PT 04743565T PT 04743565 T PT04743565 T PT 04743565T PT 1651774 E PT1651774 E PT 1651774E
Authority
PT
Portugal
Prior art keywords
leu
ser
ile
gly
rosuvastatin
Prior art date
Application number
PT04743565T
Other languages
English (en)
Portuguese (pt)
Inventor
Helen Jean Ambrose
Ruth March
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1651774E publication Critical patent/PT1651774E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Semiconductor Lasers (AREA)
PT04743565T 2003-07-26 2004-07-26 Utilização de polimorfismos na oatp-c humana, associados com um efeito sobre a farmacocinética da estatina, em humanos em terapia com estatina PT1651774E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0317592.4A GB0317592D0 (en) 2003-07-26 2003-07-26 Method

Publications (1)

Publication Number Publication Date
PT1651774E true PT1651774E (pt) 2007-11-16

Family

ID=27772801

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04743565T PT1651774E (pt) 2003-07-26 2004-07-26 Utilização de polimorfismos na oatp-c humana, associados com um efeito sobre a farmacocinética da estatina, em humanos em terapia com estatina

Country Status (12)

Country Link
US (1) US7700277B2 (cg-RX-API-DMAC7.html)
EP (1) EP1651774B1 (cg-RX-API-DMAC7.html)
JP (1) JP4166257B2 (cg-RX-API-DMAC7.html)
AT (1) ATE373730T1 (cg-RX-API-DMAC7.html)
CY (1) CY1107801T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004009083T2 (cg-RX-API-DMAC7.html)
DK (1) DK1651774T3 (cg-RX-API-DMAC7.html)
ES (1) ES2291899T3 (cg-RX-API-DMAC7.html)
GB (1) GB0317592D0 (cg-RX-API-DMAC7.html)
PL (1) PL1651774T3 (cg-RX-API-DMAC7.html)
PT (1) PT1651774E (cg-RX-API-DMAC7.html)
WO (1) WO2005012566A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006008656A2 (en) * 2004-07-21 2006-01-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Oatp-c gene c463a polymorphism underlies variable response of statin therapy
WO2009106838A1 (en) * 2008-02-29 2009-09-03 Isis Innovation Limited Diagnostic methods
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
CA2851838A1 (en) 2011-10-13 2013-04-18 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
CA2968221A1 (en) 2014-11-17 2016-05-26 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
US10572811B2 (en) * 2015-01-29 2020-02-25 Splunk Inc. Methods and systems for determining probabilities of occurrence for events and determining anomalous events
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
CN110904215A (zh) * 2019-12-16 2020-03-24 西安和合医学检验所有限公司 用于同步检测slco1b1基因的两个snp位点的基因多态性的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32011A (en) * 1861-04-09 Coffee-pot
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
USRE32011E (en) 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
GB8902689D0 (en) 1989-02-07 1989-03-30 Ici Plc Assay method
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
EP0728218B1 (en) 1993-11-12 2008-01-02 PHRI Properties, Inc. Hybridization probes for nucleic acid detection, universal stems, methods and kits
WO2000008157A2 (en) 1998-08-07 2000-02-17 Axys Pharmaceuticals, Inc. Human anion transporter genes atnov
US20020090622A1 (en) * 2000-08-23 2002-07-11 Monisola Adeokun Chemical compounds

Also Published As

Publication number Publication date
DE602004009083D1 (de) 2007-10-31
WO2005012566A2 (en) 2005-02-10
CY1107801T1 (el) 2013-06-19
WO2005012566A3 (en) 2005-06-16
JP4166257B2 (ja) 2008-10-15
ATE373730T1 (de) 2007-10-15
JP2007500005A (ja) 2007-01-11
DK1651774T3 (da) 2008-01-07
DE602004009083T2 (de) 2008-06-19
US20070031838A1 (en) 2007-02-08
PL1651774T3 (pl) 2007-12-31
EP1651774B1 (en) 2007-09-19
US7700277B2 (en) 2010-04-20
EP1651774A2 (en) 2006-05-03
GB0317592D0 (en) 2003-08-27
ES2291899T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
Riazuddin et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p
US20210095345A1 (en) Method of identifying disease risk factors
US20100104579A1 (en) Trex1 as a marker for lupus erythematosus
Ota et al. Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population
Al-Bustan et al. Genetic association of APOB polymorphisms with variation in serum lipid profile among the Kuwait population
ES2252159T3 (es) Polimorfismos en el gen humano del transportador de anion organico c (oatp-c).
WO2002098355A2 (en) Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
US7700277B2 (en) Use of polymorphisms in human OATP-C associated with an effect on statin pharmacokinetics in humans in statin therapy
Peces et al. Severe congenital nephrogenic diabetes insipidus in a compound heterozygote with a new large deletion of the AQP2 gene. A case report
WO2010102387A1 (en) Interleukin-12 polymorphisms for identifying risk for primary biliary cirrhosis
Bruikman et al. Genetic variants in SUSD2 are associated with the risk of ischemic heart disease
JP5601685B2 (ja) Apo(a)遺伝子における多型はアセチルサリチル酸治療に対する応答性を予測する
Wang et al. Association of the single-nucleotide polymorphism in the MFG-E8 gene with coronary heart disease in Chinese Han population
CA2813327A1 (en) Genetic modifiers of cystic fibrosis
Feng et al. Sequence variants of the POMC gene and their associations with body composition in children
JP2010528262A5 (cg-RX-API-DMAC7.html)
KR20060096437A (ko) 비만증에 대한 유전적 표식형질
US20060177860A1 (en) Genetic markers in the HLA-DQBI gene associated with an adverse hematological response to drugs
US20060183146A1 (en) Genetic markers in the HLA-C gene associated with an adverse hematological response to drugs
MXPA06014924A (es) Procedimientos para predecir la respuesta terapeutica frente a agentes que actuan en el receptor de la hormona del crecimiento.
JP2008525000A (ja) 統合失調症及び関連障害を治療するための組成物及び方法
US20070122803A1 (en) Methods for the detection of polymorphisms in the human oatpf gene
Zhang et al. Association analysis of BANK1 gene with psoriasis in Southern Han Chinese
US20090149428A1 (en) Methods for Assessing the Predisposition or Susceptibility to COPD
JP2008534019A (ja) ヒトニーマンピックc1様1遺伝子(npc1l1)多型及びその使用方法